Nutritional risk assessment and inspiration for patients in chemotherapy after radical gastrectomy
10.3760/cma.j.issn.1672-7088.2017.16.001
- VernacularTitle:胃癌根治术后患者化疗期营养风险的动态评估及饮食指导启示
- Author:
Qingrong QU
;
Chengshu YANG
;
Weifang HE
;
Yige XU
- Keywords:
Drug therapy;
combination;
Radical gastrectomy;
Nutritional assessment;
Dietary guidance
- From:
Chinese Journal of Practical Nursing
2017;33(16):1201-1204
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the nutritional status of patients with chemotherapy after radical gastrectomy and to provide dietary guidance and nutritional support for patients in time. Methods Patients who received chamotherary after radical gastrectomy inthe Gastrointestinal Surgery of the First Affiliated Hospital of Zhengzhou University from September 2014 to March 2016 were included in the study. The nutritional status was assessed by unified training investigators within 48 h after hospitalization. The questionnaires of Scored Patient-Generated Subjective Global Assessment (PG-SGA) and the Chemotherapy Side Effects of Patients with Gastric Cancer Questionnaire were used to investigatethe patients by trained investigators. Results The scores of the nutritional status of patients with different stages of chemotherapy were 6.107 ± 2.947, 6.505 ± 3.134, 8.068 ± 3.748, which was statistically significant (F=10.202, P<0.01). The incidence of anorexia was the highest rate of diet-related symptoms, the rate of early, mid-term and later chemotherapy rates were 34.95%(36/103), 56.31%(58/103), and 75.73%(78/103) respectively. Patients acquired the diet knowledge mainly from medical staff. The proportions of early, middle and later stages of chemotherapy were 92.23% (95/103), 79.61% (82/103), 75.73%(78/103). Conclusions With the increase of chemotherapy times, the nutritional status of patients with radical gastrectomy is getting worse. The results suggested that medical staff should provide an effective basis dietary guidance in time, improving the patients′nutritional status and clinical outcomes.
